Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Influenza

Free Subscription Articles published in Virology Retrieve available abstracts of 111 articles: HTML format

Single Articles

July 2025
1. LIU R, Song F, Sun L, Yan F, et al
   Exploring the pathogenic and transmission characteristics of JN.1 in golden hamsters based on different attack methods.
   Virology. 2025;608:110548.
   PubMed     Abstract available
   
   
   
2. CAO L, Shi S, Zhang C, Zhao C, et al
   A phycobiliprotein-based reporter assay for the evaluation of SARS-CoV-2 main protease activity.
   Virology. 2025;608:110540.
   PubMed     Abstract available
   
   
   June 2025
3. CHAKRABORTY C, Bhattacharya M, Abdelhameed AS
   Recent SARS-CoV-2 evolution trajectories indicate the emergence of Omicron's several subvariants and the current rise of KP.3.1.1 and XEC.
   Virology. 2025;607:110508.
   PubMed     Abstract available
   
   
   
4. ANDERSON M, Lopez J, Wyr M, Ramirez PW, et al
   Defining diverse spike-receptor interactions involved in SARS-CoV-2 entry: Mechanisms and therapeutic opportunities.
   Virology. 2025;607:110507.
   PubMed     Abstract available
   
   
   
5. BEAUDOIN-BUSSIERES G, Tauzin A, Dionne K, El Ferri O, et al
   Multiple exposures to SARS-CoV-2 Spike enhance cross-reactive antibody-dependent cellular cytotoxicity against SARS-CoV-1.
   Virology. 2025;607:110512.
   PubMed     Abstract available
   
   
   May 2025
6. ISHIGAKI H, Itoh Y
   Translational research on pandemic virus infection using nonhuman primate models.
   Virology. 2025;606:110511.
   PubMed     Abstract available
   
   
   
7. DAS SARMA J
   Murine beta-coronavirus spike protein: A major determinant of neuropathogenic properties.
   Virology. 2025;606:110499.
   PubMed     Abstract available
   
   
   
8. LUNDRIGAN E, Uguccioni S, Hum C, Ahmed N, et al
   SARS-CoV-2 Nsp13 helicase modulates miR-146a-mediated signaling pathways.
   Virology. 2025;606:110493.
   PubMed     Abstract available
   
   
   April 2025
9. REUSS D, Brown JC, Sukhova K, Furnon W, et al
   Interference between SARS-CoV-2 and influenza B virus during coinfection is mediated by induction of specific interferon responses in the lung epithelium.
   Virology. 2025;608:110556.
   PubMed     Abstract available
   
   
   March 2025
10. RAHA JR, Kim KH, Tien Le CT, Bhatnagar N, et al
    A strategy of enhancing the protective efficacy of seasonal influenza vaccines by providing additional immunity to neuraminidase and M2e.
    Virology. 2025;606:110510.
    PubMed     Abstract available
    
    
    
11. BANGA NDZOUBOUKOU JL, Kamara AA, Ullah N, Lei Q, et al
    A meta-analysis on the immunogenicity of prototype, monovalent-adapted and bivalent vaccines against SARS-CoV-2 wildtype, Omicron BA.1 and Omicron BA.4/5 in healthy adults.
    Virology. 2025;606:110509.
    PubMed     Abstract available
    
    
    
12. OSPINA-JIMENEZ AF, Gomez AP, Rincon-Monroy MA, Perez DR, et al
    A novel reassorted swine H3N2 influenza virus demonstrates an undetected human-to-swine spillover in Latin America and highlights zoonotic risks.
    Virology. 2025;606:110483.
    PubMed     Abstract available
    
    
    
13. PAWAR SD, Keng SS, Tare DS, Balakrishnan A, et al
    Evidence of novel reassortment in clade 2.3.4.4b avian influenza H5N1 viruses, India, 2024.
    Virology. 2025;606:110482.
    PubMed     Abstract available
    
    
    
14. LAI SK, Lee ZQ, Tan TI, Tan BH, et al
    Evidence that the cell glycocalyx envelops respiratory syncytial virus (RSV) particles that form on the surface of RSV-infected human airway cells.
    Virology. 2025;604:110415.
    PubMed     Abstract available
    
    
    
15. HILLS FR, Geoghegan JL, Bostina M
    Architects of infection: A structural overview of SARS-related coronavirus spike glycoproteins.
    Virology. 2025;604:110383.
    PubMed     Abstract available
    
    
    
16. PORTER SM, Hartwig AE, Quilici M, Bosco-Lauth AM, et al
    Intraspecific SARS-CoV-2 Delta variant transmission among red fox (Vulpes vulpes) and striped skunk (Mephitis mephitis).
    Virology. 2025;604:110446.
    PubMed     Abstract available
    
    
    
17. HE M, He CQ, Ding NZ
    Human viruses: An ever-increasing list.
    Virology. 2025;604:110445.
    PubMed     Abstract available
    
    
    
18. SHI H, Inankur B, Yin J
    Serum starvation impacts rhinovirus spread from cell to cell.
    Virology. 2025;604:110408.
    PubMed     Abstract available
    
    
    
19. SUGRUE RJ, Tan BH
    The link between respiratory syncytial virus (RSV) morphogenesis and virus transmission: Towards a paradigm for understanding RSV transmission in the upper airway.
    Virology. 2025;604:110413.
    PubMed     Abstract available
    
    
    
20. YAMAMOTO A, Ito H, Sakaguchi T, Higashiura A, et al
    Structural insights into nucleocapsid protein variability: Implications for PJ34 efficacy against SARS-CoV-2.
    Virology. 2025;604:110411.
    PubMed     Abstract available
    
    
    February 2025
21. BENLARBI M, Kenfack DD, Dionne K, Cote-Chenette M, et al
    Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon.
    Virology. 2025;605:110467.
    PubMed     Abstract available
    
    
    
22. HARADA R, Hiono T, Igarashi M, Kobayashi D, et al
    Altered receptor-binding specificity of gull-adapted H13 avian influenza viruses corresponds to their unique host preferences.
    Virology. 2025;605:110460.
    PubMed     Abstract available
    
    
    
23. MILLER JL, Niewiesk S
    Review of impaired immune parameters in RSV infections in the elderly.
    Virology. 2025;603:110395.
    PubMed     Abstract available
    
    
    
24. JONES LR
    Intra-host variability of SARS-CoV-2: Patterns, causes and impact on COVID-19.
    Virology. 2025;603:110366.
    PubMed     Abstract available
    
    
    
25. ROY K, Saikia BK, Konwar R
    Exploring the role of carbon quantum dots as countermeasure for SARS-CoV-2 virus.
    Virology. 2025;603:110339.
    PubMed     Abstract available
    
    
    
26. POPOVIC ME, Tadic V, Popovic M
    (R)evolution of Viruses: Introduction to biothermodynamics of viruses.
    Virology. 2025;603:110319.
    PubMed     Abstract available
    
    
    January 2025
27. FRAGOSO-SAAVEDRA M, Liu Q
    Towards developing multistrain PEDV vaccines: Integrating basic concepts and SARS-CoV-2 pan-sarbecovirus strategies.
    Virology. 2025;604:110412.
    PubMed     Abstract available
    
    
    
28. PATEL H, Kukol A
    Harnessing viral internal proteins to combat flu and beyond.
    Virology. 2025;604:110414.
    PubMed     Abstract available
    
    
    
29. HASSAN MSH, Sharif S
    Immune responses to avian influenza viruses in chickens.
    Virology. 2025;603:110405.
    PubMed     Abstract available
    
    
    
30. NI M, Lin S, Shao Y, Tang J, et al
    Enteric pathogenicity characterization of emerging parainfluenza virus 5 in western China.
    Virology. 2025;604:110409.
    PubMed     Abstract available
    
    
    
31. ZHAO Y, Li W, Xu L, Tao Z, et al
    Antibody responses in omicron BF.7-infected patients vaccinated with inactivated SARS-CoV-2.
    Virology. 2025;603:110404.
    PubMed     Abstract available
    
    
    
32. SAHA A, Choudhary S, Walia P, Kumar P, et al
    Transformative approaches in SARS-CoV-2 management: Vaccines, therapeutics and future direction.
    Virology. 2025;604:110394.
    PubMed     Abstract available
    
    
    
33. LV X, Zheng T, Lei X, Ren L, et al
    RTP4 restricts influenza A virus infection by targeting the viral NS1 protein.
    Virology. 2025;603:110397.
    PubMed     Abstract available
    
    
    
34. ZHIRNOV OP, Chernyshova AI
    The uncleaved viral hemagglutinin HA0 increases influenza A virus resistance to thermal pasteurization.
    Virology. 2025;604:110389.
    PubMed     Abstract available
    
    
    
35. SULTANA R, Stahelin RV
    Strengths and limitations of SARS-CoV-2 virus-like particle systems.
    Virology. 2025;601:110285.
    PubMed     Abstract available
    
    
    December 2024
36. CALDERON-PEREZ B, Nunez-Munoz LA, Trejo-Ayala LL, Rosales-Garcia VH, et al
    Immunogenicity of a multivalent protein subunit vaccine based on non-glycosylated RBD antigens of SARS-cov-2 and its variants.
    Virology. 2024;603:110380.
    PubMed     Abstract available
    
    
    
37. MCKENNA S, Jung KI, Wolf JJ, Seo YJ, et al
    Multiple sphingolipid-metabolizing enzymes modulate influenza virus replication.
    Virology. 2024;603:110367.
    PubMed     Abstract available
    
    
    
38. OO A, Chen Z, Cao D, Cho YJ, et al
    Biochemical simulation of mutation synthesis and repair during SARS-CoV-2 RNA polymerization.
    Virology. 2024;600:110255.
    PubMed     Abstract available
    
    
    
39. NOWAK R, Gazecka M, Hoffmann M, Kierzek R, et al
    TMPRSS2-specific antisense oligonucleotides inhibit host cell entry of emerging viruses.
    Virology. 2024;600:110218.
    PubMed     Abstract available
    
    
    
40. WANG C, Zhang Y, Yang C, Ren W, et al
    Receptor binding mechanism and immune evasion capacity of SARS-CoV-2 BQ.1.1 lineage.
    Virology. 2024;600:110241.
    PubMed     Abstract available
    
    
    
41. WANG M, Valadez-Ingersoll M, Gilmore TD
    Control of nuclear localization of the nucleocapsid protein of SARS-CoV-2.
    Virology. 2024;600:110232.
    PubMed     Abstract available
    
    
    November 2024
42. YANG S, Yang X, Zhu W, Luo C, et al
    The novel COVID-19 treatment VV116 is a potential inhibitor of Zika virus.
    Virology. 2024;603:110334.
    PubMed     Abstract available
    
    
    
43. KEGEL NB, Kaufmann A, Matrosovich M, Bauer S, et al
    Decomposition of L-glutamine and accumulation of ammonium in cell culture media inhibit infectivity of influenza viruses.
    Virology. 2024;602:110314.
    PubMed     Abstract available
    
    
    
44. ZHAO Q, Zhang J, Yang S, Bai X, et al
    H1N1 swine influenza viruses upregulate NEU1 expression through histone H3 acetylation regulated by HDAC2.
    Virology. 2024;601:110305.
    PubMed     Abstract available
    
    
    October 2024
45. WU Y, Lai SK, En-Zuo Chan C, Tan BH, et al
    Evidence that the SARS-CoV-2 S protein undergoes a conformational change at the Golgi complex that leads to the formation of virus neutralising antibody binding epitopes in the S1 protein subunit.
    Virology. 2024;598:110187.
    PubMed     Abstract available
    
    
    September 2024
46. LIU J, Chen K, Wu W, Pang Z, et al
    GRP78 exerts antiviral function against influenza A virus infection by activating the IFN/JAK-STAT signaling.
    Virology. 2024;600:110249.
    PubMed     Abstract available
    
    
    
47. CHAKRABORTY C, Bhattacharya M
    Evolution and mutational landscape of highly pathogenic avian influenza strain A(H5N1) in the current outbreak in the USA and global landscape.
    Virology. 2024;600:110246.
    PubMed     Abstract available
    
    
    
48. BENITO AA, Monteagudo LV, Lazaro-Gaspar S, Mazas-Cabetas L, et al
    Detection and subtyping of influenza A virus in porcine clinical samples from Spain in 2020.
    Virology. 2024;600:110223.
    PubMed     Abstract available
    
    
    
49. ROOT JJ, Porter SM, Lenoch JB, Ellis JW, et al
    Susceptibilities and viral shedding of peridomestic wildlife infected with clade 2.3.4.4b highly pathogenic avian influenza virus (H5N1).
    Virology. 2024;600:110231.
    PubMed     Abstract available
    
    
    
50. LEI Y, Xu N, Niu C, Chen L, et al
    Specific immunological characteristics and risk factor of XBB variants re-infection in nasopharyngeal carcinoma patients after BA.5 infection.
    Virology. 2024;597:110142.
    PubMed     Abstract available
    
    
    
51. LIANG Z, Wang J, Zhang H, Gao L, et al
    Peptide S4 is an entry inhibitor of SARS-CoV-2 infection.
    Virology. 2024;597:110149.
    PubMed     Abstract available
    
    
    
52. DUDEK I, Czerkies M, Kwiatek A
    Differential expression of cytokines and elevated levels of MALAT1 - Long non-coding RNA in response to non-structural proteins of human respiratory syncytial virus.
    Virology. 2024;597:110127.
    PubMed     Abstract available
    
    
    August 2024
53. RZYMSKI P, Niedziela J, Poniedzialek B, Rosinska J, et al
    Humoral anti-SARS-CoV-2 response in patients with different long COVID phenotypes.
    Virology. 2024;596:110118.
    PubMed     Abstract available
    
    
    July 2024
54. MANDVIWALA AS, Huckriede ALW, Arankalle VA, Patil HP, et al
    Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice.
    Virology. 2024;598:110194.
    PubMed     Abstract available
    
    
    
55. CAI M, Wei Z, Hu X, Ji Y, et al
    The evolution, complexity, and diversity of swine influenza viruses in China: A hidden public health threat.
    Virology. 2024;598:110167.
    PubMed     Abstract available
    
    
    
56. LIU J, Ren T, Wang X, Wang H, et al
    The emergence, isolation, and phylogenetic analysis of a closely related human strain of parainfluenza virus 5 from a case of porcine reproductive and respiratory syndrome in China.
    Virology. 2024;597:110157.
    PubMed     Abstract available
    
    
    
57. LEE J, Naoe Y, Bang U, Nakagama Y, et al
    Neutralization sensitivity of SARS-CoV-2 Omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera.
    Virology. 2024;595:110067.
    PubMed     Abstract available
    
    
    
58. GILLOT C, Tre-Hardy M, Cupaiolo R, Blairon L, et al
    Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273.
    Virology. 2024;595:110082.
    PubMed     Abstract available
    
    
    
59. UENO S, Amarbayasgalan S, Sugiura Y, Takahashi T, et al
    Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication.
    Virology. 2024;595:110068.
    PubMed     Abstract available
    
    
    June 2024
60. ZHU H, Li X, Li X, Chen H, et al
    Protection against the H1N1 influenza virus using self-assembled nanoparticles formed by lumazine synthase and bearing the M2e peptide.
    Virology. 2024;597:110162.
    PubMed     Abstract available
    
    
    
61. NAVEED A, Yu J, Lawson S, Gao R, et al
    Receptor binding and immunogenic properties of the receptor binding domain of influenza D virus hemagglutinin-esterase-fusion protein expressed from Escherichia coli.
    Virology. 2024;597:110138.
    PubMed     Abstract available
    
    
    
62. NGUYEN CT, Nakayama M, Ishigaki H, Kitagawa Y, et al
    Increased expression of CD38 on endothelial cells in SARS-CoV-2 infection in cynomolgus macaques.
    Virology. 2024;594:110052.
    PubMed     Abstract available
    
    
    
63. GE P, Ross TM
    COBRA HA and NA vaccination elicits long-live protective immune responses against pre-pandemic H2, H5, and H7 influenza virus subtypes.
    Virology. 2024;597:110119.
    PubMed     Abstract available
    
    
    May 2024
64. DUCATEZ MF, Wang C, Yang J, Zhao Y, et al
    Infection dynamics of subtype H9N2 low pathogenic avian influenza a virus in turkeys.
    Virology. 2024;596:110124.
    PubMed     Abstract available
    
    
    
65. TIAN Y, Deng Z, Chuai Z, Li C, et al
    A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge.
    Virology. 2024;596:110125.
    PubMed     Abstract available
    
    
    
66. BROGAARD L, Heegaard PMH, Larsen LE, Skovgaard K, et al
    Pulmonary MicroRNA expression after heterologous challenge with swine influenza A virus (H1N2) in immunized and non-immunized pigs.
    Virology. 2024;596:110117.
    PubMed     Abstract available
    
    
    
67. HUANG J, Ma K, Zhang J, Zhou J, et al
    Pathogenicity and transmission of novel highly pathogenic H7N2 variants originating from H7N9 avian influenza viruses in chickens.
    Virology. 2024;597:110121.
    PubMed     Abstract available
    
    
    
68. SAIKIA BK, Roy K, Konwar R
    Preliminary report on therapeutic potential of coal-derived carbon quantum dots against SARS-CoV-2 virus.
    Virology. 2024;593:110036.
    PubMed     Abstract available
    
    
    
69. LIU J, Gao L, Zhou N, Jiang Z, et al
    p53 suppresses the inflammatory response following respiratory syncytial virus infection by inhibiting TLR2.
    Virology. 2024;593:110018.
    PubMed     Abstract available
    
    
    April 2024
70. MA X, Wang Q, Xu X, Zhang W, et al
    miR-214-PTEN pathway is a potential mechanism for stress-induced immunosuppression affecting chicken immune response to avian influenza virus vaccine.
    Virology. 2024;595:110094.
    PubMed     Abstract available
    
    
    
71. KIM KH, Bhatnagar N, Subbiah J, Liu R, et al
    Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets.
    Virology. 2024;595:110097.
    PubMed     Abstract available
    
    
    
72. VALLERIANI F, Di Pancrazio C, Spedicato M, Di Teodoro G, et al
    A cell-adapted SARS-CoV-2 mutant, showing a deletion in the spike protein spanning the furin cleavage site, has reduced virulence at the lung level in K18-hACE2 mice.
    Virology. 2024;592:109997.
    PubMed     Abstract available
    
    
    
73. ALTINA NH, Maranon DG, Anderson JR, Donaldson MK, et al
    The leader RNA of SARS-CoV-2 sequesters polypyrimidine tract binding protein (PTBP1) and influences pre-mRNA splicing in infected cells.
    Virology. 2024;592:109986.
    PubMed     Abstract available
    
    
    March 2024
74. BRIGGS K, Chrzastek K, Segovia K, Mo J, et al
    Genetic insertion of mouse Myxovirus-resistance gene 1 increases innate resistance against both high and low pathogenic avian influenza virus by significantly decreasing replication in chicken DF1 cell line.
    Virology. 2024;595:110066.
    PubMed     Abstract available
    
    
    
75. SAKA N, Nishio M, Ohta K
    Human parainfluenza virus type 2 V protein inhibits mitochondrial apoptosis pathway through two ways.
    Virology. 2024;594:110053.
    PubMed     Abstract available
    
    
    
76. ZHENG X, Yang R, Zhao Y, Zhang Y, et al
    Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity.
    Virology. 2024;594:110050.
    PubMed     Abstract available
    
    
    
77. HUONG TN, Lee ZQ, Lai SK, Lee HY, et al
    Evidence that an interaction between the respiratory syncytial virus F and G proteins at the distal ends of virus filaments mediates efficient multiple cycle infection.
    Virology. 2024;591:109985.
    PubMed     Abstract available
    
    
    February 2024
78. HUANG Y, Zhang P, Han S, Hu B, et al
    Effect of Enteromorpha polysaccharides on gut-lung axis in mice infected with H5N1 influenza virus.
    Virology. 2024;593:110031.
    PubMed     Abstract available
    
    
    
79. MA B, Tao M, Li Z, Zheng Q, et al
    Mucosal vaccines for viral diseases: Status and prospects.
    Virology. 2024;593:110026.
    PubMed     Abstract available
    
    
    
80. YANG J, Lan R, Chang H, Li H, et al
    Isolation and characterization of genotype 4 Eurasian avian-like H1N1 influenza virus in pigs suffering from pneumonia.
    Virology. 2024;592:110009.
    PubMed     Abstract available
    
    
    
81. LEE DW, Kim JM, Kim DW, Kim JY, et al
    Three distinct ORF1a recombinants of the SARS-CoV-2 Delta variant of concern.
    Virology. 2024;590:109945.
    PubMed     Abstract available
    
    
    January 2024
82. FANG K, Song W, Zhang Y, Zheng Y, et al
    Comparative analysis and prediction of avian influenza in Shangrao city, China from 2016 to 2022.
    Virology. 2024;592:109995.
    PubMed     Abstract available
    
    
    
83. YUAN F, Yang L, Hsiao SH, Herndon NL, et al
    A neonatal piglet model reveals interactions between nasal microbiota and influenza A virus pathogenesis.
    Virology. 2024;592:109996.
    PubMed     Abstract available
    
    
    
84. ZHANG Y, Wang D, Xiang Q, Hu X, et al
    A potent neutralizing nanobody targeting a unique epitope on the receptor-binding domain of SARS-CoV-2 spike protein.
    Virology. 2024;589:109925.
    PubMed     Abstract available
    
    
    December 2023
85. TANG C, Carrera Montoya J, Fritzlar S, Flavel M, et al
    Polyphenol rich sugarcane extract (PRSE) has potential antiviral activity against influenza A virus in vitro.
    Virology. 2023;590:109969.
    PubMed     Abstract available
    
    
    
86. BIALY D, Richardson S, Chrzastek K, Bhat S, et al
    Recombinant A(H6N1)-H274Y avian influenza virus with dual drug resistance does not require permissive mutations to retain the replicative fitness in vitro and in ovo.
    Virology. 2023;590:109954.
    PubMed     Abstract available
    
    
    November 2023
87. RAMEY AM, Scott LC, Ahlstrom CA, Buck EJ, et al
    Molecular detection and characterization of highly pathogenic H5N1 clade 2.3.4.4b avian influenza viruses among hunter-harvested wild birds provides evidence for three independent introductions into Alaska.
    Virology. 2023;589:109938.
    PubMed     Abstract available
    
    
    
88. ZHU M, Zeng H, He J, Zhu Y, et al
    Reassortant H9N2 canine influenza viruses containing the pandemic H1N1/2009 ribonucleoprotein complex circulating in pigs acquired enhanced virulence in mice.
    Virology. 2023;589:109927.
    PubMed     Abstract available
    
    
    
89. NAIQING X, Tang X, Wang X, Cai M, et al
    Hemagglutinin affects replication, stability and airborne transmission of the H9N2 subtype avian influenza virus.
    Virology. 2023;589:109926.
    PubMed     Abstract available
    
    
    October 2023
90. AFRIN SZ, Sathi FA, Nooruzzaman M, Parvin R, et al
    Molecular insights into the SARS-CoV-2 Omicron variant from Bangladesh suggest diverse and continuous evolution.
    Virology. 2023;587:109882.
    PubMed     Abstract available
    
    
    September 2023
91. BRIGGS K, Sweeney R, Blehert DS, Spackman E, et al
    SARS-CoV-2 utilization of ACE2 from different bat species allows for virus entry and replication in vitro.
    Virology. 2023;586:122-129.
    PubMed     Abstract available
    
    
    
92. RAMIREZ KA, Mond J, Papenburg J, Boivin G, et al
    In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infections.
    Virology. 2023;586:115-121.
    PubMed     Abstract available
    
    
    
93. XIAO Y, Wang L, Fang SS, Luo F, et al
    Direct blue 53, a biological dye, inhibits SARS-CoV-2 infection by blocking ACE2 and spike interaction in vitro and in vivo.
    Virology. 2023;586:105-114.
    PubMed     Abstract available
    
    
    August 2023
94. TEWARI DN, Biswas A, Chakrabarti AK, Dutta S, et al
    AMFR promotes innate immunity activation and proteasomal degradation of HMGCR in response to influenza virus infection in A549 cells.
    Virology. 2023;587:109875.
    PubMed     Abstract available
    
    
    
95. UPRETY T, Sreenivasan CC, Thomas M, Hause B, et al
    Prevalence and characterization of seven-segmented influenza viruses in bovine respiratory disease complex.
    Virology. 2023;587:109859.
    PubMed     Abstract available
    
    
    
96. YOUK S, Torchetti MK, Lantz K, Lenoch JB, et al
    H5N1 highly pathogenic avian influenza clade 2.3.4.4b in wild and domestic birds: Introductions into the United States and reassortments, December 2021-April 2022.
    Virology. 2023;587:109860.
    PubMed     Abstract available
    
    
    
97. MARANO JM, Cereghino C, Finkielstein CV, Weger-Lucarelli J, et al
    An in vitro workflow to create and modify infectious clones using replication cycle reaction.
    Virology. 2023;585:109-116.
    PubMed     Abstract available
    
    
    
98. SILVA JUNIOR JVJ, Duraes-Carvalho R, de Souza JR, Ramos Janini LM, et al
    Emergence of SARS-CoV-2 serotype(s): Is it a matter of time?
    Virology. 2023;585:78-81.
    PubMed     Abstract available
    
    
    July 2023
99. ZHOU H, Liu J, Li L, Sun J, et al
    Circulation of influenza C virus of C/Sao Paulo/378/82 lineage among pediatric acute respiratory cases, Shandong, China.
    Virology. 2023;587:109855.
    PubMed     Abstract available
    
    
    June 2023
100. TANG L, Liu X, Wang C, Shu C, et al
     USP18 promotes innate immune responses and apoptosis in influenza A virus-infected A549 cells via cGAS-STING pathway.
     Virology. 2023;585:240-247.
     PubMed     Abstract available
     
     
     
101. SU R, Shi Z, Li E, Zhu M, et al
     A Trim-RBD-GEM vaccine candidate protects mice from SARS-CoV-2.
     Virology. 2023;585:145-154.
     PubMed     Abstract available
     
     
     
102. YILMAZ B, Cakmak Genc G, Karakas Celik S, Piskin N, et al
     The 3'UTR region of the DNA repair gene PARP-1 May increase the severity of COVID-19 by altering the binding of antiviral miRNAs.
     Virology. 2023;583:29-35.
     PubMed     Abstract available
     
     
     
103. POTTAGE T, Onianwa O, Atkinson B, Spencer A, et al
     Stability of SARS-CoV-2 variants of concern (Delta and Omicron) on surfaces at room temperature.
     Virology. 2023;583:27-28.
     PubMed     Abstract available
     
     
     
104. PFANZAGL B
     The ICAM-1 ligand HRV-A89 is internalized independently of clathrin-mediated endocytosis and its capsid reaches late endosomes.
     Virology. 2023;583:45-51.
     PubMed     Abstract available
     
     
     May 2023
105. CHENCHULA S, Amerneni KC, Ghanta MK, Padmavathi R, et al
     Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA.5.2.1.7): A systematic review.
     Virology. 2023;584:38-43.
     PubMed     Abstract available
     
     
     
106. SUN X, Belser JA, Kieran TJ, Brock N, et al
     Enhanced fitness of SARS-CoV-2 B.1.617.2 Delta variant in ferrets.
     Virology. 2023;582:57-61.
     PubMed     Abstract available
     
     
     
107. MAYER AM, Grohs Ferrareze PA, de Oliveira LFV, Gregianini TS, et al
     Genomic characterization and molecular evolution of SARS-CoV-2 in Rio Grande do Sul State, Brazil.
     Virology. 2023;582:1-11.
     PubMed     Abstract available
     
     
     April 2023
108. BOSCO-LAUTH A, Rodriguez A, Maison RM, Porter SM, et al
     H7N9 influenza A virus transmission in a multispecies barnyard model.
     Virology. 2023;582:100-105.
     PubMed     Abstract available
     
     
     
109. KANDWAL S, Fayne D
     Genetic conservation across SARS-CoV-2 non-structural proteins - Insights into possible targets for treatment of future viral outbreaks.
     Virology. 2023;581:97-115.
     PubMed     Abstract available
     
     
     March 2023
110. HUONG TN, Ravi Iyer L, Lui J, Wang Y, et al
     The respiratory syncytial virus SH protein is incorporated into infectious virus particles that form on virus-infected cells.
     Virology. 2023;580:28-40.
     PubMed     Abstract available
     
     
     October 2022
111. LAMICHHANE P, Schmidt ME, Terhuja M, Varga SM, et al
     A live single-cycle RSV vaccine expressing prefusion F protein.
     Virology. 2022;577:51-64.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.